← Open Payments lookup

BRANDI PAUGH: Open Payments

NPI 1982104360 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$454 in 24 payments from 8 companies in 2025. Trend: 2023 $688 · 2024 $633 · 2025 $454

Food & beverage: $454
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$155
Astellas Pharma US Inc7$147
Novo Nordisk Inc2$46
Currax Pharmaceuticals LLC2$32
GlaxoSmithKline, LLC.1$24
Lilly USA, LLC1$19
ABBVIE INC.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: Veozah, AIRSUPRA, FARXIGA, JARDIANCE, Ozempic, TRELEGY ELLIPTA, BREZTRI, Rybelsus.

Industry payments across MD — which companies pay providers there.